Why COLVERA?
4-8
30-50% of CRC patients may experience a recurrence of their CRC1.
76%
Positive predictive value (PPV)2 “detected” via COLVERA when confirmed with radiological recurrence.
98%
Specificity3 provided by COLVERA.
96%
Negative predictive value (NPV)4.
1 Primrose et al, JAMA 2014 ; Snyder et al, JAMA 2018 ; NCCN Clinical Practice Guidelines (Colon and Rectal Cancer), 2020.
2 Positive predictive value is the probability that subjects with a positive screening test truly have the disease.
3 Specificity measures a test’s ability to correctly generate a negative result for people who don’t have the condition that’s being tested.
4 Negative predictive value is the probability that subjects with a negative screening test truly don't have the disease.